Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: AstraZeneca AB
Drug Studied: AZD9496
National Clinical Trial #: NCT02780713
Protocol #: D6090C00005
Study Date: June 2016 to September 2016
Short Study Title: A study in healthy participants to see how
different forms of AZD9496 act in the body
and if they cause medical problems
Thank you!
As a clinical study participant, you belong to a large community
of participants around the world. You help researchers answer
important health questions and discover new medical treatments.
Thank you for taking part in the clinical study for the drug AZD9496.
This drug is being developed to treat breast cancer. You and all of the
participants helped researchers learn how AZD9496 acts in the body
and if the drug causes medical problems.
AstraZeneca AB, the sponsor of this study, thanks you for your help
and thinks it is important for you to know the results of your study.
An independent non-profit organization called CISCRP prepared
this summary of the study results for you with the help of a medical
writing organization. We hope it helps you understand and feel
proud of your important role in medical research. If you have
questions about the results, please speak with the doctor or staff
at your study site.
1